Atrial fibrillation and CHADS2 risk factors are associated with highly sensitive C-reactive protein incrementally and independently.
about
Statin Therapy for Primary Prevention of Atrial Fibrillation: Guided by CHADS2/CHA2DS2VASc Score.B-type natriuretic peptide and C-reactive protein in the prediction of atrial fibrillation risk: the CHARGE-AF Consortium of community-based cohort studies.Cognitive impairment associated with atrial fibrillation: a meta-analysis.A Circulating Biomarker Risk-Prediction Model Correlates with CHADS-2 Risk Score in Chronic Atrial Fibrillation.Relationship of the total atrial conduction time to subclinical atherosclerosis, inflammation and echocardiographic parameters in patients with type 2 diabetes mellitus.Atrial Fibrillation Patients Treated With Long-Term Warfarin Anticoagulation Have Higher Rates of All Dementia Types Compared With Patients Receiving Long-Term Warfarin for Other Indications.Adverse Outcomes from Atrial Fibrillation;Mechanisms, Risks, and Insights Learned from Therapeutic Options.Atrial fibrillation, stroke, and quality of life.Biomarkers in atrial fibrillation: a clinical review.The impact of atrial fibrillation and its treatment on dementia.C-reactive protein gene polymorphism predicts the risk of thromboembolic stroke in patients with atrial fibrillation: a more than 10-year prospective follow-up study.The association between atrial fibrillation and cognitive function in patients with heart failure.Atrial fibrillation hospitalization is not increased with short-term elevations in exposure to fine particulate air pollution.Association between vascular comorbidity and progression of Alzheimer's disease: a two-year observational study in Norwegian memory clinics.
P2860
Q33984012-81E2F1CF-A9D3-494D-A026-8E9D86AD7D82Q34342621-E0733D1E-8AD8-499F-97D1-C5B6AEC2AE86Q34608086-2678FCB6-9DC6-4824-873B-1D246F4589AAQ35105438-AC1024E4-F60F-429F-9E0A-22DB1E82AAFEQ35152618-CAFCDE21-2F4F-4438-92D1-E7171D823302Q37240808-D6F52455-AB0F-4D2E-8330-E1FD0B83073DQ37495633-CEAAFC8B-07F4-420F-A670-5568D73C7776Q38006746-3F3D37BA-EC9E-4B5F-AC1D-239660A2DCE3Q38079565-3EA0A7C5-21D7-4EA0-AF98-28817EAD1A71Q38224058-2B4E8A74-22CB-4E55-9F64-335812AE964FQ38789345-F5B149AB-7B4F-4C49-B0E2-ADA8082AF909Q38795931-34B7451D-4C4E-4823-9886-7E536661CB47Q48284477-16AB6CCB-641F-49CE-B6FA-35DF961EA1C8Q55257582-FD4B9370-DB1B-4184-8945-0DF818C9840F
P2860
Atrial fibrillation and CHADS2 risk factors are associated with highly sensitive C-reactive protein incrementally and independently.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Atrial fibrillation and CHADS2 ...... crementally and independently.
@en
Atrial fibrillation and CHADS2 ...... crementally and independently.
@nl
type
label
Atrial fibrillation and CHADS2 ...... crementally and independently.
@en
Atrial fibrillation and CHADS2 ...... crementally and independently.
@nl
prefLabel
Atrial fibrillation and CHADS2 ...... crementally and independently.
@en
Atrial fibrillation and CHADS2 ...... crementally and independently.
@nl
P2093
P1476
Atrial fibrillation and CHADS2 ...... crementally and independently.
@en
P2093
Benjamin D Horne
Brian G Crandall
Donald L Lappé
J Peter Weiss
Jeffrey L Anderson
John D Day
Joseph B Muhlestein
Mark A Crandall
T Jared Bunch
P2860
P304
P356
10.1111/J.1540-8159.2009.02339.X
P577
2009-05-01T00:00:00Z